See how your AI readiness compares across the industry
What's inside:
Why 50% of pharma companies struggle to scale AI in production
What the top 10% AI-ready companies are doing that you can implement
-1.svg){kind=icon}
A simple 3-step action from Lingaro’s expert analysis for each AI dimension
What you get:
Why 50% of pharma companies struggle to scale AI in production
What the top 10% AI-ready companies are doing that you can implement
A simple 3-step action from Lingaro’s expert analysis for each AI dimension
AI in pharma is moving fast. Most organizations do not.
This report is for you if you’re a:
- Commercial, medical, digital, or data leader in pharma or life sciences
- Decision-maker evaluating where to invest in AI next
- Leader responsible for AI adoption, data strategy, or digital transformation
With this report, you can address:
- Lack of industry benchmarks: See aggregated, real-world data on where pharma organizations are on AI.
- No clear starting point: Get a grounded picture of where peers are beginning their AI journeys and what is working.
- Misaligned priorities: Understand the most common gaps between AI ambition and execution so you can focus on what matters most.
